To verify the role of CXCR4 and CD133 in ovarian cancer patients, CXCR4, CD133, CD44, CD24 were evaluated in 37 surgically resected primary ovarian epithelial tumors (Table 2). This evidence concerns the gene PROM1 and ovarian cancer.